Unprecedented success in trialling new adult leukaemia therapy Posted on December 13, 2013February 25, 2018 by Carly du Toit A new, potentially life-saving drug has raised new hope for patients in advanced stages of chronic lymphocytic leukaemia – one of the most common types of adult leukaemia in Australia. In many cases this cancer becomes resistant to traditional treatment methods such as chemotherapy. This is because of its high levels of a “pro-survival” protein called BCL-2 that render cancer cells, according to Walter and Eliza Hall Institute haematologist Prof. Andrew Roberts “basically indestructible”. Continue reading “Unprecedented success in trialling new adult leukaemia therapy”
ACRF-funded cancer research centre will speed up the fight against Leukaemia Posted on April 3, 2012February 25, 2018 by Carly du Toit A new research centre set to fast-track leukaemia discoveries and other types of blood cancer research from the lab to the hospital bedside was opened today by the Victorian Minister for Health, David Davis. Established through a $1 million grant from the ACRF, The Australian Cancer Research Foundation (ACRF) Centre for Translational Research will provide new hope to thousands of people with blood cancers. The facility is located at The Royal Melbourne Hospital, which sees more than 120 new leukaemia cases and performs some 80 bone marrow transplants each year. The Translational Research Centre will therefore provide a seamless link between the Hospital and collaborating research facilities, including the Walter and Eliza Hall Institute of Medical Research, the University of Melbourne and The Royal Melbourne’s Diagnostic Haematology Laboratory and clinical services. Executive Director of Research at The Royal Melbourne Hospital, Prof Ingrid Winship said such a centre was vital to improve outcomes for patients. Continue reading “ACRF-funded cancer research centre will speed up the fight against Leukaemia”
